Loading company…
PharmEnable combines medicinal chemistry and AI to develop therapeutics.
PharmEnable uses its chemSAILOR and chemUNIVERSE platforms to identify and design molecules for biological targets. Its projects include work on cancer and neurology. Founded in 2016, the company is based in Cambridge, UK. It raised USD 7.5 million in venture funding led by MP Healthcare Venture Management in May 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in